Medications

BDNF–VEGF interplay key to rapid antidepressant actions

A study by researchers at Yale University reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine. The study, published in Biological Psychiatry, reports ...

Oncology & Cancer

Methylation signaling controls angiogenesis and cancer growth

A study led by researchers at Boston University School of Medicine (BUSM) demonstrates a new mechanism involving a signaling protein and its receptor that may block the formation of new blood vessels and cancer growth. The ...

Diabetes

Approved cancer drug potentially could help treat diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway—a series of interaction among proteins—involved in the development of diabetes. Furthermore, they have ...

Oncology & Cancer

VEGF may not be relevant biomarker for advanced prostate cancer

The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University ...

page 5 from 10